Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
38.75
-0.05 (-0.13%)
At close: Jul 8, 2026, 4:00 PM EDT
38.80
+0.05 (0.13%)
After-hours: Jul 8, 2026, 4:10 PM EDT
Nanobiotix Market Cap
Nanobiotix has a market cap or net worth of $1.93 billion as of July 8, 2026. Its market cap has increased by 741.44% in one year.
Market Cap
1.93B
Enterprise Value
1.98B
1-Year Change
741.44%
Ranking
Category
Stock Price
$38.75
Market Cap Chart
Since the IPO on December 11, 2020, Nanobiotix's market cap has increased from $549.07M to $1.93B, an increase of 251.93%. That is a compound annual growth rate of 25.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 1.93B | 74.45% |
| Dec 31, 2025 | 1.11B | 646.33% |
| Dec 31, 2024 | 148.41M | -57.08% |
| Dec 29, 2023 | 345.77M | 156.45% |
| Dec 30, 2022 | 134.83M | -53.41% |
| Dec 31, 2021 | 289.40M | -50.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AnaptysBio | 1.99B |
| Nuvation Bio | 1.97B |
| Precigen | 1.96B |
| Zymeworks | 1.95B |
| Iovance Biotherapeutics | 1.94B |
| Absci | 1.92B |
| AtaiBeckley | 1.91B |
| Rapport Therapeutics | 1.90B |